ATE63821T1 - Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes. - Google Patents

Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.

Info

Publication number
ATE63821T1
ATE63821T1 AT88201499T AT88201499T ATE63821T1 AT E63821 T1 ATE63821 T1 AT E63821T1 AT 88201499 T AT88201499 T AT 88201499T AT 88201499 T AT88201499 T AT 88201499T AT E63821 T1 ATE63821 T1 AT E63821T1
Authority
AT
Austria
Prior art keywords
met
diabetes
preventing
medication
combating
Prior art date
Application number
AT88201499T
Other languages
English (en)
Inventor
Robby Huisman
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of ATE63821T1 publication Critical patent/ATE63821T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT88201499T 1987-08-14 1988-07-13 Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes. ATE63821T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8701912 1987-08-14
EP88201499A EP0303308B1 (de) 1987-08-14 1988-07-13 Präparat zur Verhütung oder Bekämpfung von Komplikationen bei Diabetes

Publications (1)

Publication Number Publication Date
ATE63821T1 true ATE63821T1 (de) 1991-06-15

Family

ID=19850453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88201499T ATE63821T1 (de) 1987-08-14 1988-07-13 Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.

Country Status (9)

Country Link
EP (1) EP0303308B1 (de)
JP (1) JPS6466129A (de)
KR (1) KR890003403A (de)
AT (1) ATE63821T1 (de)
AU (1) AU612169B2 (de)
DE (1) DE3863027D1 (de)
DK (1) DK418788A (de)
NZ (1) NZ225621A (de)
ZA (1) ZA885502B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
AU3497093A (en) * 1992-02-17 1993-09-03 Akzo N.V. Anti-neuropathic composition
WO1993023072A1 (en) * 1992-05-13 1993-11-25 Akzo N.V. Aqueous hexapeptide compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
IL66611A0 (en) * 1981-08-27 1982-12-31 Lilly Co Eli Pharmaceutical formulations comprising human insulin and human c-peptide
CA1196863A (en) * 1983-06-08 1985-11-19 Mattheus F.A. Goosen Slow release injectable insulin composition
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system

Also Published As

Publication number Publication date
DK418788D0 (da) 1988-07-26
KR890003403A (ko) 1989-04-14
NZ225621A (en) 1990-11-27
AU612169B2 (en) 1991-07-04
EP0303308B1 (de) 1991-05-29
JPS6466129A (en) 1989-03-13
EP0303308A1 (de) 1989-02-15
AU2063388A (en) 1989-02-16
DE3863027D1 (de) 1991-07-04
ZA885502B (en) 1989-04-26
DK418788A (da) 1989-02-15

Similar Documents

Publication Publication Date Title
ATA260690A (de) Therapeutische infusionszubereitung auf basis von aminosäurederivaten
DE69033040D1 (de) Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF)
FI875533A0 (fi) Insulinpreparat foer non-parenteral dosering.
DK340088A (da) Aminosyrederivater
ATE84414T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.
DE68915207D1 (de) Aminosäure-Derivate.
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
ATE106746T1 (de) Arzneimittel zur subkutanen oder intramuskulären applikation enthaltend polypeptide.
NO884434L (no) Aminosyrederivater.
FI892185A (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi
FI875295A (fi) Menetelmä hirudiinivariantin valmistamiseksi
YU108691A (sh) Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
ATE63821T1 (de) Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
DE3751586D1 (de) Antitumor-Aminosäuren und Peptid-Derivate von 1,4-bis[(Aminoalkyl und Hydroxyaminoalkyl)amino]5,8-Dihydroxyanthraquinonen.
IT1198238B (it) Composti ad attivita' antibiotica
EP0303251A3 (en) Modified tpa-containing injection composition
ATE70454T1 (de) Vincristin enthaltendes produkt.
DE3772687D1 (de) Arzneimittel zur heilung von arteriosklerose, enthaltend ein pyrimido(2,1-b)benzothiazol-derivat.
DE68908958D1 (de) Peptide.
EP0296227A4 (de) Verabreichung von aminosäuren durch die nase.
EP0274106A3 (de) N-(Trans-p-hydroxy-cyclohexyl)-(2-amino-3,5-dibromo)benzylamin-Salze mit mukolytischer Wirkung
SE8703567D0 (sv) Aminosyralosning for intravenos infusion
DK0440100T3 (da) Anvendelse af et galdesyresalt og et lipid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee